cjc-1295 ipamorelin information & Blend (10mg) What Is CJC 1295 Ipamorelin?
Description
Conflict of interest JA, VF-S, and JJ are co-inventors of the US Patents 9, 889, 156, Method for treating NIHL and 9, 919, 008, Methods for treating ARHL. Both patents are based on the use of oral ACEMg, but currently, they are not involved in any trials testing this compound or any other commercial exploitation
, & Kim, J
doi: 10.1186/s12934-024-02446-6
Beide Peptide sind im Bodybuilding als heilungsbeschleunigende Supplements etabliert
